Search Results for 'amyris'

Amyris Shutters Clean Beauty Retailer Onda Beauty

Amyris Shutters Clean Beauty Retailer Onda Beauty

August 21, 2023 |

In California, Amyris, a renewable chemicals and consumer goods firm that recently declared bankruptcy, has closed its Onda Beauty brand. According to Beauty Matter, Onda Beauty was launched in 2014 by Larissa Thompson, Sarah Bryden-Brown, and actress Naomi Watts. Onda Beauty was subsequently acquired by Amyris in April 2022 amid a buying spree of consumer-focused brands.

Read More

Amyris’ bankruptcy filing: Complete details

Amyris’ bankruptcy filing: Complete details

August 10, 2023 |

Here follows the complete Amyris statement with respect to its Chapter 11 bankruptcy filing. Amyris, Inc. (Nasdaq: AMRS) (“Amyris” or the “Company”), a leading synthetic biotechnology company accelerating the world’s transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced that it is moving forward with an operational and […]

Read More

Amyris announces job cuts, CEO departure

Amyris announces job cuts, CEO departure

June 26, 2023 |

In California, synbio and natural beauty products company Amyris has announced the resignation of John Melo from his position as president and CEO and as a member of the Board of Directors, effective immediately. Amyris’s Board of Directors appointed Han Kieftenbeld, currently Amyris CFO, as the Interim CEO. “John’s unwavering commitment and leadership have played […]

Read More

Amyris and Croda sign squalene supply deal

Amyris and Croda sign squalene supply deal

May 22, 2023 |

In California, synthetic biology leader Amyris, Inc. has signed an exclusive license agreement with British specialty chemicals company Croda International for the supply of biobased squalene. Squalene is commonly derived from shark liver, but Amyris’ sugarcane-derived, sustainable squalene is molecularly identical to the traditional shark source and offers a higher purity, more predictable cost profile […]

Read More

The Digest’s 2023 Multi-Slide Guide to Amyris

The Digest’s 2023 Multi-Slide Guide to Amyris

May 11, 2023 |

By engineering the genetics of yeast strains and fermenting them in sugarcane syrup, Amyris pioneered the ability to convert basic plant sugars to hydrocarbon molecules. To date, the company has successfully created and commercialized 13 sustainable ingredients that are used by hundreds of millions of people, in products made by more than 3,000 top global […]

Read More

The Digest’s 2023 Multi-Slide Guide to Amyris

The Digest’s 2023 Multi-Slide Guide to Amyris

March 16, 2023 |

Powered by Amyris. Powerful words — the company ingredients and products are used all over the world. But how exactly does the company make “people and our planet healthier as the leading provider of clean, sustainable chemistry”?They cite their “advantaged business model” including technology, brand power and lab-to-market operating platform including newly expanded capacity in […]

Read More

Amyris sells Squalane, Neossance, and CleanScreen to Givaudan

Amyris sells Squalane, Neossance, and CleanScreen to Givaudan

February 27, 2023 |

In California, synthetic biology firm Amyris has sold three ingredients to beauty and fragrance major Givaudan. The products sold include performant emollient Neossance® Squalane; plant-based silicone alternative Neossance® Hemisqualane; and sun protector CleanScreen. Givaudan and Amyris also signed a long-term partnership agreement under which Amyris will continue to manufacture ingredients for Givaudan to use in […]

Read More

Amyris announces $50 million common stock offering

Amyris announces $50 million common stock offering

January 2, 2023 |

In California, renewable chemical maker Amyris, Inc. has entered into a definitive purchase agreement for stock and announced a concurrent private placement, saying the combination will net about $50 million. The funds will be used for general corporate purposes. The definitive purchase agreement covers the purchase and sale of 20,000,000 shares of the Company’s common […]

Read More

Amyris awaiting antitrust review to complete exclusive rights to supply two if its ingredients

Amyris awaiting antitrust review to complete exclusive rights to supply two if its ingredients

December 27, 2022 |

In California, Amyris, Inc. has completed the negotiation of key financial and business terms of the previously communicated strategic transaction for the exclusive rights to supply two of Amyris’ ingredients. The transaction is subject to antitrust review under the Hart-Scott-Rodino Act (“HSR”) with a standard waiting period of thirty days. Accordingly, the transaction is expected […]

Read More

The Digest’s 2022 Multi-Slide ABLC Guide to Amyris

The Digest’s 2022 Multi-Slide ABLC Guide to Amyris

November 9, 2022 |

By engineering the genetics of yeast strains and fermenting them in sugarcane syrup, Amyris pioneered the ability to convert basic plant sugars to hydrocarbon molecules. To date, the company has successfully created and commercialized 13 sustainable ingredients that are used by hundreds of millions of people, in products made by more than 3,000 top global […]

Read More